These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7247796)

  • 1. Carbidopa-levodopa ratio in Parkinson's disease.
    Weiner WJ; Nausieda PA
    Arch Neurol; 1981 Aug; 38(8):534. PubMed ID: 7247796
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease.
    Lieberman AN; Gopinathan G; Neophytides A; Pasternack P
    N Y State J Med; 1986 Dec; 86(12):655-6. PubMed ID: 3468386
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined therapy of carbidopa and levodopa in Parkinson's disease].
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):201-4. PubMed ID: 4075908
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of levodopa with carbidopa, and levodopa with domperidone in Parkinson's disease.
    Langdon N; Malcolm PN; Parkes JD
    Clin Neuropharmacol; 1986; 9(5):440-7. PubMed ID: 3768866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
    Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease.
    Tourtellotte WW; Syndulko K; Potvin AR; Hirsch SB; Potvin JH
    Arch Neurol; 1980 Nov; 37(11):723-6. PubMed ID: 7436817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.
    Reichmann H; Emre M
    Expert Rev Neurother; 2012 Feb; 12(2):119-31. PubMed ID: 22288667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease.
    Guthikonda LN; Lyons KE; Pahwa R
    J Comp Eff Res; 2014 Jul; 3(4):331-3. PubMed ID: 25275230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release carbidopa-levodopa in Parkinson's disease.
    Rascol O
    Lancet Neurol; 2013 Apr; 12(4):325-6. PubMed ID: 23485609
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".
    Lambarth AT
    CNS Drugs; 2016 Oct; 30(10):1007-8. PubMed ID: 27541607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease].
    Bermejo Pareja F; Martínez-Martín P
    Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.
    Gilligan B; Wodak J; Stark R; O'Halloran M
    Med J Aust; 1979 Aug; 2(4):205-7. PubMed ID: 390336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease.
    Hutton JT; Morris JL
    Neurology; 1992 Jan; 42(1 Suppl 1):51-6; discussion 57-60. PubMed ID: 1549202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".
    Wirdefeldt K; Odin P; Nyholm D
    CNS Drugs; 2016 Oct; 30(10):1009-10. PubMed ID: 27541606
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct endoscopic jejunosotomy for the administration of levodopa-carbidopa intestinal gel in Parkinson's disease.
    Kimber TE; Schoeman M
    Parkinsonism Relat Disord; 2014 Jul; 20(7):786-8. PubMed ID: 24721490
    [No Abstract]   [Full Text] [Related]  

  • 16. Jejunal levodopa infusion in Parkinson's disease.
    Rascol O
    Lancet Neurol; 2014 Feb; 13(2):128-9. PubMed ID: 24361113
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease.
    Busk K; Nyholm D
    Parkinsonism Relat Disord; 2012 Sep; 18(8):1000-1. PubMed ID: 22546333
    [No Abstract]   [Full Text] [Related]  

  • 18. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):112. PubMed ID: 26218794
    [No Abstract]   [Full Text] [Related]  

  • 19. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
    Hely MA; Morris JG; Rail D; Reid WG; O'Sullivan DJ; Williamson PM; Genge S; Broe GA
    J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):324-8. PubMed ID: 2647907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to letter: Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Marano M; Salomone G; di Biase L; Di Lazzaro V; Melgari JM
    Parkinsonism Relat Disord; 2016 Apr; 25():114-5. PubMed ID: 26698016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.